http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104721678-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-9062 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10 |
| filingDate | 2014-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104721678-B |
| titleOfInvention | Application of galangal extract in preparation of anti-osteoporosis medicine |
| abstract | Galangal (Alpinia officinarum Hance, AOH) is the rhizome of galangal of dicotyledonous plant, Zingiberaceae, and the research group finds that galangal extract and galangal extract comprise galangal as raw material, and are subjected to crude extraction by a solvent extraction method and crude separation by a column chromatography method to obtain three compounds with different polarities, namely low-polarity compounds are enriched volatile oil extracts, medium-polarity compounds are enriched flavonoid extracts and high-polarity compounds are enriched diphenyl heptane extracts, which have obvious prevention and treatment effects on ovarian-removed rat osteoporosis, therefore, the invention provides the application of galangal extract or galangal extract in preparing a medicament for clinically preventing and treating osteoporosis, and meanwhile, the galangal extract or galangal extract can also be prepared into capsules, soft capsules, tablets, granules, oral liquid and sprays, the injection is applied to the aspect of clinically used as a medicine for preventing and treating osteoporosis. |
| priorityDate | 2014-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 421.